Precision Biosciences (DTIL) Retained Earnings (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Retained Earnings data on file, last reported at -$546.6 million in Q1 2026.

• On a quarterly basis, Retained Earnings fell 8.67% year-over-year to -$546.6 million in Q1 2026; TTM through Mar 2026 was -$546.6 million, a 8.67% decrease from a year earlier, with the FY2025 full-year figure at -$528.2 million, down 9.48% from the prior year.
• Retained Earnings for Q1 2026 stood at -$546.6 million, down from -$528.2 million in the prior quarter.
• Over the last five years, Retained Earnings for DTIL reached as high as -$344.8 million in Q1 2022 and fell as low as -$548.3 million in Q3 2025.
• Historically, Retained Earnings has averaged -$468.2 million across 5 years, with a median of -$473.3 million in 2023.
• Across the five-year window, Retained Earnings sank 35.82% in 2022 and gained 3.65% in 2024, its largest moves.
• Year by year, Retained Earnings stood at -$428.3 million in 2022, then declined by 14.32% to -$489.6 million in 2023, then climbed by 1.46% to -$482.5 million in 2024, then retreated by 9.48% to -$528.2 million in 2025, then dropped by 3.49% to -$546.6 million in 2026.
• Per Business Quant data, the three most recent Retained Earnings figures were -$546.6 million in Q1 2026, -$528.2 million in Q4 2025, and -$548.3 million in Q3 2025.